PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för Yosprala. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

13 hits

Bibliografisk träff 2017-02-23

The budget impact of using enteric-coated aspirin 325 mg + immediate-release omeprazole 40 mg to prevent recurrent cardiovascular events.

Zhang W, Han Y, Fort JG, Schofield D, Tursi JP.

J Med Econ · journal article · DOI 10.1080/13696998.2017.1289940

Bibliografisk träff 2017-01-01

Efficacy of aspirin (325 mg) + omeprazole (40 mg) in treating coronary artery disease.

Sharma T, Bliden K, Chaudhary R, Tantry U, Gurbel PA.

Expert Opin Pharmacother · review; journal article · DOI 10.1080/14656566.2016.1269747

Bibliografisk träff 2017-01-01

Yosprala - a combination of aspirin and omeprazole.

Författaruppgift saknas

Med Lett Drugs Ther · review; journal article

Bibliografisk träff 2016-08-01

Aspirin Use in Secondary Cardiovascular Protection and the Development of Aspirin-Associated Erosions and Ulcers.

Goldstein JL, Scheiman JM, Fort JG, Whellan DJ.

J Cardiovasc Pharmacol · randomized controlled trial; journal article · DOI 10.1097/fjc.0000000000000387

Bibliografisk träff 2016-04-01

Long-Term Safety of a Coordinated Delivery Tablet of Enteric-Coated Aspirin 325 mg and Immediate-Release Omeprazole 40 mg for Secondary Cardiovascular Disease Prevention in Patients at GI Risk.

Goldstein JL, Whellan DJ, Scheiman JM, Cryer BL, Eisen GM, Lanas A, Fort JG.

Cardiovasc Ther · clinical trial, phase iii; research support, non-u.s. gov't; research-article; journal article · DOI 10.1111/1755-5922.12172

Bibliografisk träff 2014-10-10

PA32540 for the secondary prevention of cardiovascular disease in patients at risk for aspirin-associated gastric ulcers.

Duffy D, Rooney B, Adams S, Whellan DJ.

Expert Rev Cardiovasc Ther · other; research support, non-u.s. gov't; review; journal article · DOI 10.1586/14779072.2014.967214

Bibliografisk träff 2014-06-09

PA32540 (a coordinated-delivery tablet of enteric-coated aspirin 325 mg and immediate-release omeprazole 40 mg) versus enteric-coated aspirin 325 mg alone in subjects at risk for aspirin-associated gastric ulcers: results of two 6-month, phase 3 studies.

Whellan DJ, Goldstein JL, Cryer BL, Eisen GM, Lanas A, Miller AB, Scheiman JM, Fort JG, Zhang Y, O'Connor C.

Am Heart J · clinical trial, phase iii; multicenter study; randomized controlled trial; journal article · DOI 10.1016/j.ahj.2014.05.017

Bibliografisk träff 2014-03-01

Severe leukopenia in a rheumatoid arthritis patient treated with a methotrexate/leflunomide combination.

Toth P, Bernd R.

Rev Bras Reumatol · journal article; case reports · DOI 10.1016/j.rbr.2014.03.011

Bibliografisk träff 2013-11-01

PA tablets: investigational compounds combining aspirin and omeprazole for cardioprotection.

Bliden KP, Brener M, Gesheff MG, Franzese CJ, Tabrizchi A, Tantry U, Gurbel PA.

Future Cardiol · review; journal article · DOI 10.2217/fca.13.67

Bibliografisk träff 2013-05-21

Intragastric acidity and omeprazole exposure during dosing with either PA32540 (enteric-coated aspirin 325 mg + immediate-release omeprazole 40 mg) or enteric-coated aspirin 325 mg + enteric-coated omeprazole 40 mg - a randomised, phase 1, crossover study.

Miner PB, Fort JG, Zhang Y.

Aliment Pharmacol Ther · research support, non-u.s. gov't; clinical trial, phase i; randomized controlled trial; journal article · DOI 10.1111/apt.12340

Bibliografisk träff 2012-12-04

Spaced administration of PA32540 and clopidogrel results in greater platelet inhibition than synchronous administration of enteric-coated aspirin and enteric-coated omeprazole and clopidogrel.

Gurbel PA, Bliden KP, Fort JG, Jeong YH, Shuldiner A, Chai S, Gesheff T, Antonino M, Gesheff M, Zhang Y, Tantry US.

Am Heart J · comparative study; research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1016/j.ahj.2012.07.032

Bibliografisk träff 2011-11-02

Pharmacodynamic evaluation of clopidogrel plus PA32540: the Spaced PA32540 With Clopidogrel Interaction Gauging (SPACING) study.

Gurbel PA, Bliden KP, Fort J, Zhang Y, Plachetka JR, Antonino M, Gesheff M, Tantry US.

Clin Pharmacol Ther · research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1038/clpt.2011.201

Bibliografisk träff 2007-10-26

Reversible hearing loss in temporal association with chemoprophylactic mefloquine use.

Wise M, Toovey S.

Travel Med Infect Dis · journal article; case reports · DOI 10.1016/j.tmaid.2007.08.006